Compare GKOS & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | SYM |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.9B |
| IPO Year | 2015 | 2021 |
| Metric | GKOS | SYM |
|---|---|---|
| Price | $116.56 | $53.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | ★ $133.07 | $57.46 |
| AVG Volume (30 Days) | 661.7K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $507,442,000.00 | ★ $2,246,922,000.00 |
| Revenue This Year | $23.30 | $24.75 |
| Revenue Next Year | $27.43 | $27.90 |
| P/E Ratio | ★ N/A | $2,677.50 |
| Revenue Growth | ★ 32.33 | 25.65 |
| 52 Week Low | $73.16 | $19.14 |
| 52 Week High | $130.23 | $87.88 |
| Indicator | GKOS | SYM |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 52.39 |
| Support Level | $104.72 | $48.17 |
| Resistance Level | $123.16 | $57.65 |
| Average True Range (ATR) | 4.70 | 2.62 |
| MACD | 1.71 | 0.49 |
| Stochastic Oscillator | 69.51 | 65.56 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.